392 related articles for article (PubMed ID: 31402861)
1. Formononetin: A Review of Its Anticancer Potentials and Mechanisms.
Tay KC; Tan LT; Chan CK; Hong SL; Chan KG; Yap WH; Pusparajah P; Lee LH; Goh BH
Front Pharmacol; 2019; 10():820. PubMed ID: 31402861
[TBL] [Abstract][Full Text] [Related]
2. Formononetin inhibits migration and invasion of MDA-MB-231 and 4T1 breast cancer cells by suppressing MMP-2 and MMP-9 through PI3K/AKT signaling pathways.
Zhou R; Xu L; Ye M; Liao M; Du H; Chen H
Horm Metab Res; 2014 Oct; 46(11):753-60. PubMed ID: 24977660
[TBL] [Abstract][Full Text] [Related]
3. Honokiol: A Review of Its Anticancer Potential and Mechanisms.
Ong CP; Lee WL; Tang YQ; Yap WH
Cancers (Basel); 2019 Dec; 12(1):. PubMed ID: 31877856
[TBL] [Abstract][Full Text] [Related]
4. Formononetin, a novel FGFR2 inhibitor, potently inhibits angiogenesis and tumor growth in preclinical models.
Wu XY; Xu H; Wu ZF; Chen C; Liu JY; Wu GN; Yao XQ; Liu FK; Li G; Shen L
Oncotarget; 2015 Dec; 6(42):44563-78. PubMed ID: 26575424
[TBL] [Abstract][Full Text] [Related]
5. The potential role of formononetin in cancer treatment: An updated review.
Aliya S; Alhammadi M; Park U; Tiwari JN; Lee JH; Han YK; Huh YS
Biomed Pharmacother; 2023 Dec; 168():115811. PubMed ID: 37922652
[TBL] [Abstract][Full Text] [Related]
6. Formononetin, an isoflavone from Astragalus membranaceus inhibits proliferation and metastasis of ovarian cancer cells.
Zhang J; Liu L; Wang J; Ren B; Zhang L; Li W
J Ethnopharmacol; 2018 Jul; 221():91-99. PubMed ID: 29660466
[TBL] [Abstract][Full Text] [Related]
7. Focus on Formononetin: Anticancer Potential and Molecular Targets.
Ong SKL; Shanmugam MK; Fan L; Fraser SE; Arfuso F; Ahn KS; Sethi G; Bishayee A
Cancers (Basel); 2019 May; 11(5):. PubMed ID: 31052435
[TBL] [Abstract][Full Text] [Related]
8. Formononetin promotes cell cycle arrest via downregulation of Akt/Cyclin D1/CDK4 in human prostate cancer cells.
Li T; Zhao X; Mo Z; Huang W; Yan H; Ling Z; Ye Y
Cell Physiol Biochem; 2014; 34(4):1351-8. PubMed ID: 25301361
[TBL] [Abstract][Full Text] [Related]
9. Formononetin mediates neuroprotection against cerebral ischemia/reperfusion in rats via downregulation of the Bax/Bcl-2 ratio and upregulation PI3K/Akt signaling pathway.
Liang K; Ye Y; Wang Y; Zhang J; Li C
J Neurol Sci; 2014 Sep; 344(1-2):100-4. PubMed ID: 24996490
[TBL] [Abstract][Full Text] [Related]
10. Formononetin induces cell cycle arrest of human breast cancer cells via IGF1/PI3K/Akt pathways in vitro and in vivo.
Chen J; Zeng J; Xin M; Huang W; Chen X
Horm Metab Res; 2011 Sep; 43(10):681-6. PubMed ID: 21932171
[TBL] [Abstract][Full Text] [Related]
11. Potential Therapeutic Targets of Formononetin, a Type of Methoxylated Isoflavone, and Its Role in Cancer Therapy through the Modulation of Signal Transduction Pathways.
Almatroodi SA; Almatroudi A; Khan AA; Rahmani AH
Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298670
[TBL] [Abstract][Full Text] [Related]
12. Synergistic Anticancer Effects of Formononetin and Temozolomide on Glioma C6 Cells.
Zhang X; Ni Q; Wang Y; Fan H; Li Y
Biol Pharm Bull; 2018 Aug; 41(8):1194-1202. PubMed ID: 29848900
[TBL] [Abstract][Full Text] [Related]
13. Formononetin-induced apoptosis of human prostate cancer cells through ERK1/2 mitogen-activated protein kinase inactivation.
Ye Y; Hou R; Chen J; Mo L; Zhang J; Huang Y; Mo Z
Horm Metab Res; 2012 Apr; 44(4):263-7. PubMed ID: 22328166
[TBL] [Abstract][Full Text] [Related]
14. Formononetin suppresses the proliferation of human non-small cell lung cancer through induction of cell cycle arrest and apoptosis.
Yang Y; Zhao Y; Ai X; Cheng B; Lu S
Int J Clin Exp Pathol; 2014; 7(12):8453-61. PubMed ID: 25674209
[TBL] [Abstract][Full Text] [Related]
15. Formononetin-induced apoptosis by activation of Ras/p38 mitogen-activated protein kinase in estrogen receptor-positive human breast cancer cells.
Chen J; Sun L
Horm Metab Res; 2012 Dec; 44(13):943-8. PubMed ID: 22828872
[TBL] [Abstract][Full Text] [Related]
16. The O-methylated isoflavone, formononetin, inhibits human ovarian cancer cell proliferation by sub G0/G1 cell phase arrest through PI3K/AKT and ERK1/2 inactivation.
Park S; Bazer FW; Lim W; Song G
J Cell Biochem; 2018 Sep; 119(9):7377-7387. PubMed ID: 29761845
[TBL] [Abstract][Full Text] [Related]
17. Sea cucumber extract TBL-12 inhibits the proliferation, migration, and invasion of human prostate cancer cells through the p38 mitogen-activated protein kinase and intrinsic caspase apoptosis pathway.
Yuan L; Huang X; Zhou K; Zhu X; Huang B; Qiu S; Cao K; Xu L
Prostate; 2019 Jun; 79(8):826-839. PubMed ID: 30889629
[TBL] [Abstract][Full Text] [Related]
18. Formononetin inhibits colon carcinoma cell growth and invasion by microRNA‑149‑mediated EphB3 downregulation and inhibition of PI3K/AKT and STAT3 signaling pathways.
Wang AL; Li Y; Zhao Q; Fan LQ
Mol Med Rep; 2018 Jun; 17(6):7721-7729. PubMed ID: 29620230
[TBL] [Abstract][Full Text] [Related]
19. Formononetin potentiates epirubicin-induced apoptosis via ROS production in HeLa cells in vitro.
Lo YL; Wang W
Chem Biol Interact; 2013 Oct; 205(3):188-97. PubMed ID: 23867903
[TBL] [Abstract][Full Text] [Related]
20. Formononetin accelerates wound repair by the regulation of early growth response factor-1 transcription factor through the phosphorylation of the ERK and p38 MAPK pathways.
Huh JE; Nam DW; Baek YH; Kang JW; Park DS; Choi DY; Lee JD
Int Immunopharmacol; 2011 Jan; 11(1):46-54. PubMed ID: 20959155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
